Minimally invasive solutions developer K2M Group Holdings has gained exclusive license of a portfolio with 17 issued and pending patents for expandable interbody technology.
The firm currently offers expandable solutions for procedures such as transforaminal lumbar interbody fusion (TLIF) lateral and posterior lumbar interbody fusion (PLIF).
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The addition of the new patents is expected to strengthen the firm’s capabilities for expandable interbody and 3D-printed offerings.
K2M plans to integrate its Lamellar 3D Titanium Technology into the new products that will be developed using the acquired intellectual property.
With an assortment of 3D-printed spinal devices, the firm provides products that can be used for complex, minimally invasive and degenerative spine procedures.
The firm has recently obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its expandable posterior-lumbar interbody device called MOJAVE PL 3D Expandable Interbody System.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataK2M has also commercially launched another expandable interbody device called SAHARA AL Expandable Stabilisation System that features an integrated screw fixation for spinal balance.
The firm’s portfolio also includes the Balance ACS platform designed to provide solutions required for addressing each vertebral segment with a 360° approach to axial, coronal and sagittal planes.
